首页> 美国卫生研究院文献>Chinese Medical Journal >Common susceptibility loci in both systemic sclerosis and localized scleroderma identified using genetic analysis
【2h】

Common susceptibility loci in both systemic sclerosis and localized scleroderma identified using genetic analysis

机译:使用遗传分析鉴定的全身硬化和局部硬皮病中的常见易感性基因座

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Scleroderma is an autoimmune fibrosing disorder that can be further subclassified as localized scleroderma (LSc) and systemic sclerosis (SSc). LSc is characterized by sclerotic and pigmented skin lesions, while SSc is a more generalized disorder of the connective tissue involving a number of organs. SSc is characterized by the thickening of dermal collagen bundles, fibrosis, and vascular abnormalities in the visceral organs.[1] Despite the differences in their morphologic features and clinical presentation, these two diseases do share some characteristics including endothelial cell dysfunction, T helper 2 (Th2) cell dominance during immune activation and excess fibrosis of the skin with similar pathologic findings, leading to the hypothesis that SSc and LSc share an underlying mechanism of pathogensis. Currently, multiple lines of evidence suggest that genetic factors may contribute to SSc susceptibility.[2] Human leukocyte antigen (HLA) genes are closely linked to SSc susceptibility, with studies describing some correlation between SSc and HLA-B, HLA-C, HLA-DRA, HLA-DRB1, HLA-DRB5, HLA-DQA1, HLA-DQB1, HLA-DMB, HLA-DOA, HLA-DPA1, HLA-DPB1, and HLA-DPB2.[2] A large number of non-HLA genes have also been reported to be associated with the development of SSc, these include connective tissue growth factor gene (TGF), signal transducer and activator of transcription gene (STAT4) amongst others [Supplementary Table 1]. However, only some of these results could be verified in additional studies and similar studies in the Chinese population remain extremely limited. Interestingly, genes like interleukin 1 (IL-1), ras homolog family member B (RHOB), family with sequence similarity 167-member A-BLK proto-oncogene (FAM167A-BLK), STAT4, interferon regulatory factor 5 gene (IRF5), HLA-DPB1, and keratin1 (KRT1) have all been linked to SSc susceptibility in the Chinese population.[3] Although it has been reported that LSc tends to exhibit some form of familial inheritance, there have been no clearly identified heritable traits for this disease. Additionally, no study, to our knowledge, has investigated the common genetic factors for LSc and SSc. Thus, it would be of significant interest to examine the susceptibility of LSc and determine whether there are any correlations between the genetic profiles of SSc and LSc. This study aimed to identify the genetic profile of LSc patients and any shared genetic features of SSc and LSc in the Chinese population. Furthermore, this study evaluated the occurance of previously described SSc loci in the Chinese population and compared their frequency with those reported in other ethnic communities.
机译:硬皮病是一种自身免疫性纤维紊乱,可进一步亚分类为局部硬皮病(LSC)和全身硬化(SSC)。 LSC的特征在于硬化和着色的皮肤病变,而SSC是涉及许多器官的结缔组织的更广泛的疾病。 SSC的特征在于皮肤胶原束,纤维化和内脏器官中的血管异常的增厚。[1]尽管它们的形态学特征和临床介绍差异,但这两种疾病确实存在一些特征,包括内皮细胞功能障碍,T辅助2(TH2)细胞优势在免疫激活和皮肤过多的皮肤纤维化中具有相似的病理发现,导致假设SSC和LSC分享病原体的潜在机制。目前,多条证据表明遗传因素可能有助于SSC易感性。[2]人的白细胞抗原(HLA)基因与SSC敏感性密切相关,研究了描述SSC和HLA-B,HLA-C,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-DQA1,HLA-DQB1之间的一些相关性的研究, HLA-DMB,HLA-DOA,HLA-DPA1,HLA-DPB1和HLA-DPB2。[2]据报道,许多非HLA基因与SSC的发育有关,这些包括结缔组织生长因子基因(TGF),信号传感器和转录基因的激活剂(Stat4)中的其他[补充表1]。然而,只有其中一些结果可以在额外的研究中核实,而中国人口的类似研究仍然非常有限。有趣的是,异种素1(IL-1)等基因,RAS同源物家庭成员B(RHOB),具有序列相似性的家族167-成员A-BLK原型(FAM167A-BLK),STAT4,干扰素调控因子5基因(IRF5) ,HLA-DPB1和角蛋白1(KRT1)都与中国人口中的SSC易感性联系起来。[3]虽然据报道,LSC倾向于表现出某种形式的家族遗产,但没有明确确定这种疾病的遗传性状。此外,迄今为止,我们的知识也没有研究LSC和SSC的常见遗传因素。因此,检查LSC的易感性并确定SSC和LSC的遗传谱之间是否存在任何相关性将是显着的兴趣。本研究旨在鉴定中国人口中SSC和LSC的任何共同遗传特征的遗传概况。此外,该研究评估了在中国人口中先前描述的SSC基因座的发生,并将其频率与其他族裔社区报告的人进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号